Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog
about
Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemiaMevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbitsA novel therapeutic effect of statins on nephrogenic diabetes insipidusA century of cholesterol and coronaries: from plaques to genes to statinsPlasma cholesterol-lowering and transient liver dysfunction in mice lacking squalene synthase in the liverInhibition of hydroxymethylglutaryl-coenzyme A synthase by L-659,699Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo.Cholesterol feeding increases low density lipoprotein synthesis.Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.Regulation of hepatic 7 alpha-hydroxylase expression by dietary psyllium in the hamster.LDL-cholesterol reduction in patients with hypercholesterolemia by modulation of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinaseIn vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene.A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis.Simvastatin: a review.Metabolism of low-density lipoproteins by cultured hepatocytes from normal and homozygous familial hypercholesterolemic subjects.Dependence of metabolic and structural heterogeneity of cholesterol ester-rich very low density lipoproteins on the duration of cholesterol feeding in rabbits.Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjectsHypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.PCSK9 is a critical regulator of the innate immune response and septic shock outcome.The Eck fistula in animals and humans.Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids.No evidence for statin-induced proteinuria in healthy volunteers as assessed by proteomic analysis.Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits.Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia.Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse.Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesisIncreased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha-ethinyl estradiol.Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ.Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor.Catabolism of low density lipoproteins by perfused rabbit livers: cholestyramine promotes receptor-dependent hepatic catabolism of low density lipoproteinsActivation of the silent endogenous cholesterol-7-alpha-hydroxylase gene in rat hepatoma cells: a new complementation group having resistance to 25-hydroxycholesterol.Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man.Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.Elevated cholesterol and bile acid synthesis in an adult patient with homozygous familial hypercholesterolemia. Reduction by a high glucose diet.Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools.Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase.
P2860
Q24611424-9C7166E4-30D3-4F1B-9BFB-D9FE87DC9CBBQ24628996-96DAA131-33B3-4EAB-B06D-DE5E50A00816Q27005638-5DA0DBCC-AC24-4BAD-ACA6-E72601D84DB0Q28080618-2C1707E9-247B-49A8-8F7C-F20695D2A7B0Q28258554-A9DE955E-FFF0-462D-9FC6-FBEE158F3DB5Q28360071-94ADAABC-CC3C-4D26-8DC1-FC67E0928971Q33566288-468175DB-4A8A-4942-B840-EA38B1A3DC37Q33821767-55015CD7-66E7-4EF6-9ECB-E8F2FFD8A83CQ33822165-B1D0DC28-33E1-46BC-A568-C2B03BAA7459Q34144772-1EE17623-E0A2-4FC1-8668-8504FA66E589Q34171169-D65E3D71-3E5A-4AC0-8DA3-049C4B2BB372Q34202163-0D25F45A-4978-4EE1-910F-AF59EF65CBEEQ34260752-8A71DF45-CC0A-4846-AA9B-03100C3E5B41Q34372227-66A5EFCD-320F-478F-AF93-348981F0073CQ34426934-DCAEBFB6-7B2C-482A-8BC5-0BBC8CA68B43Q34559811-D6D884E2-1A9C-4FE7-9901-30990181E3B3Q34602869-EDD94CF8-0D87-4AC0-A0C8-BF25146138F3Q34621428-61DAC90C-ACBC-4DDC-B1F9-CDC3915F8849Q35125516-14400AF4-15EB-41B8-90E0-B02C2E8F5956Q35160286-BC85400B-1A2C-45C6-B8FD-02FDC1543B87Q35205251-006CBE38-0481-43E2-94E9-BF8A848F2896Q35210176-DB52BEE8-6E93-4AF7-ACB7-7668C3327E5EQ35319170-66F7E633-6674-46F8-8E20-6C2F88D747E3Q35346270-E326ADA2-3564-4202-974F-A0F8FB348BC3Q35553097-E98F7B7C-0E5E-4A78-BB47-0744A733CAF2Q35583380-A78AFB72-6B48-44F1-BBEE-B5B2624617B7Q35589157-8C920138-4717-484B-94B3-DA79BD8B572BQ35819003-9FEBA6B3-634A-4FE9-B621-4CC41699F2E9Q36207373-BFC04E52-8BD3-4EE5-A414-4A497461ED0DQ36258094-8495E97D-BE0F-4E8C-9C7B-7ECD669EC9CCQ36299005-D8461C21-17C8-4EDB-958D-1B7CB10E1AFDQ36301387-E5FFE0A6-D41D-44BC-9D42-157CDD24F169Q36688460-A650DEE6-E3D4-4ED6-A7BB-D0AF3BCE4BC4Q36982518-797CEA41-3FB2-459E-85EF-DD7C45311B7AQ36984816-6F9A57AF-9ECA-41C1-B393-CD0C69E488B3Q37004383-D193B2EE-18DD-435C-AF97-E6684E08AC0AQ37004921-7F2E8D20-E644-4303-9C4E-68BF2DDB0EE7Q37005091-006CF2F0-CC60-433E-BD15-15B48A7635E3Q37297811-16A6C794-0366-4B3A-A2A1-907691E2A078Q37337988-20501729-3E99-44D3-8371-FA675094F019
P2860
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog
description
1981 nî lūn-bûn
@nan
1981 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog
@ast
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog
@en
type
label
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog
@ast
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog
@en
prefLabel
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog
@ast
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog
@en
P2093
P2860
P356
P1476
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog
@en
P2093
D W Bilheimer
J J Jaramillo
J L Goldstein
P T Kovanen
P2860
P304
P356
10.1073/PNAS.78.2.1194
P407
P577
1981-02-01T00:00:00Z